Trial Profile
A phase II/III trial of DX-103 for Mydriasis
Status:
Planning
Phase of Trial:
Phase II/III
Latest Information Update: 12 Dec 2016
Price :
$35
*
At a glance
- Drugs DX 103 (Primary)
- Indications Mydriasis
- Focus Therapeutic Use
- 12 Dec 2016 New trial record